The Journal of Hip Surgery 2017; 01(03): 152-157
DOI: 10.1055/s-0037-1606614
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Short-Term Perioperative Outcomes and Complications in Chronic Immunosuppressant Users following Total Hip Arthroplasty

Gannon L. Curtis
1   Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio
,
Morad Chughtai
1   Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio
,
Anton Khlopas
1   Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio
,
Jaiben George
1   Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio
,
Nipun Sodhi
1   Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio
,
Steven F. Harwin
2   Department of Orthopaedic Surgery, Mount Sinai West Hospital, New York, New York
,
Peter M. Bonutti
3   Bonutti Clinic, Effingham, Illinois
,
Wael K. Barsoum
1   Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio
,
Carlos A. Higuera
1   Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio
,
Michael A. Mont
1   Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio
› Author Affiliations
Further Information

Publication History

12 April 2017

14 July 2017

Publication Date:
28 September 2017 (online)

Abstract

As the rate of total hip arthroplasties (THA) being performed continues to increase, orthopaedic surgeons are likely to operate on patients who use systemic immunosuppressants for a variety of ailments. It may be necessary to continue these medications perioperatively, and it has been reported that they may affect post-operative outcomes. The authors proposed the following questions: (1) Are perioperative outcomes (i.e., operative time, lengths-of-stay, and discharge disposition) affected by chronic immunosuppressant use during THA, and (2) does chronic immunosuppressant use increase the rate of complications within 30-days of THA? The American College of Surgeons National Surgical Quality Improvement Program database was used to identify all THAs from 2008 to 2014. Only osteoarthritis diagnoses were included, and any emergency or concurrent surgeries were excluded. The authors identified 64,796 cases that met the inclusion/exclusion criteria. Prior to surgery, 1,900 patients used chronic immunosuppressants, while 62,896 patients did not use immunosuppressants. Lengths-of-stay, operative time, discharge destination, and 30-day complication rates were the measured perioperative outcomes. To determine significant outcome differences between cohorts, univariate analysis was applied. Next, multivariate regression analysis helped determine if immunosuppressant use independently increased the risk for the measured outcomes and complications. Chronic immunosuppressant users were at higher risk of certain adverse perioperative outcomes and short-term complications. Compared with the control group, immunosuppressant users were more likely to be discharged to a non-home facility (odds ratio [OR]: 1.16; 95% confidence interval [CI]: 1.03–1.31). These patients also had greater rates of septic shock (OR: 2.88; 95% CI: 1.08–7.67) and 30-day readmission (OR: 1.37; 95% CI: 1.10–1.70). Chronic immunosuppressant use leads to higher rates of complications and adverse outcomes following THA. Adverse outcomes related to immunosuppressant use included higher rates of non-home discharge. Complications related to immunosuppressant use included septic shock and 30-day readmission.

 
  • References

  • 1 Overman RA, Yeh J-Y, Deal CL. Prevalence of oral glucocorticoid usage in the United States: a general population perspective. Arthritis Care Res (Hoboken) 2013; 65 (02) 294-298
  • 2 Marik PE, Varon J. Requirement of perioperative stress doses of corticosteroids: a systematic review of the literature. Arch Surg 2008; 143 (12) 1222-1226
  • 3 Fingar KR, Stocks C, Weiss ASteiner CA. Most Frequent Operating Room Procedures Performed in U.S. Hospitals, 2003–2012. HCUP Statistical Brief #186. Rockville, MD: Agency for Healthcare Research and Quality (US); 2006
  • 4 Kurtz S, Mowat F, Ong K, Chan N, Lau E, Halpern M. Prevalence of primary and revision total hip and knee arthroplasty in the United States from 1990 through 2002. J Bone Joint Surg Am 2005; 87 (07) 1487-1497
  • 5 Kurtz SM, Ong KL, Lau E, Bozic KJ. Impact of the economic downturn on total joint replacement demand in the United States: updated projections to 2021. J Bone Joint Surg Am 2014; 96 (08) 624-630
  • 6 Shaikh KA, Helbig GM, Shapiro SA, Shah MV, Khairi SA, Horn EM. Spinal surgery following organ transplantation. J Neurosurg Spine 2011; 14 (06) 779-784
  • 7 Al-Khamis A, Abou Khalil J, Demian M. , et al. Sigmoid colectomy for acute diverticulitis in immunosuppressed vs immunocompetent patients: outcomes from the ACS-NSQIP database. Dis Colon Rectum 2016; 59 (02) 101-109
  • 8 Moghadamyeghaneh Z, Hanna MH, Blondet JJ. , et al. Impact of chronic steroid use on outcomes of colorectal surgery. Am J Surg 2015; 210 (06) 1003-1009 , discussion 1009
  • 9 Vaid S, Bell T, Grim R, Ahuja V. Predicting risk of death in general surgery patients on the basis of preoperative variables using American College of Surgeons National Surgical Quality Improvement Program data. Perm J 2012; 16 (04) 10-17
  • 10 Ismael H, Horst M, Farooq M, Jordon J, Patton JH, Rubinfeld IS. Adverse effects of preoperative steroid use on surgical outcomes. Am J Surg 2011; 201 (03) 305-308 , discussion 308–309
  • 11 Slieker JC, Komen N, Mannaerts GH, Karsten TM, Willemsen P, Murawska M. , et al. Long-term and perioperative corticosteroids in anastomotic leakage: a prospective study of 259 left-sided colorectal anastomoses. Arch Surg 2012; 147 (05) 447-452
  • 12 Wang AS, Armstrong EJ, Armstrong AW. Corticosteroids and wound healing: clinical considerations in the perioperative period. Am J Surg 2013; 206 (03) 410-417
  • 13 Cancienne JM, Werner BC, Browne JA. Complications of primary total knee arthroplasty among patients with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and osteoarthritis. J Am Acad Orthop Surg 2016; 24 (08) 567-574
  • 14 Goodman SM, Johnson B, Zhang M. , et al. Patients with rheumatoid arthritis have similar excellent outcomes after total knee replacement compared with patients with osteoarthritis. J Rheumatol 2016; 43 (01) 46-53
  • 15 Ravi B, Escott B, Shah PS. , et al. A systematic review and meta-analysis comparing complications following total joint arthroplasty for rheumatoid arthritis versus for osteoarthritis. Arthritis Rheum 2012; 64 (12) 3839-3849
  • 16 LoVerde ZJ, Mandl LA, Johnson BK. , et al. Rheumatoid arthritis does not increase risk of short-term adverse events after total knee arthroplasty: a retrospective case-control study. J Rheumatol 2015; 42 (07) 1123-1130
  • 17 Somayaji R, Barnabe C, Martin L. Risk factors for infection following total joint arthroplasty in rheumatoid arthritis. Open Rheumatol J 2013; 7 (01) 119-124
  • 18 Myers TG, Cui Q, Kuskowski M, Mihalko WM, Saleh KJ. Outcomes of total and unicompartmental knee arthroplasty for secondary and spontaneous osteonecrosis of the knee. J Bone Joint Surg Am 2006; 88 (03) (Suppl. 03) 76-82
  • 19 Singh JA, Chen J, Inacio MCS, Namba RS, Paxton EW. An underlying diagnosis of osteonecrosis of bone is associated with worse outcomes than osteoarthritis after total hip arthroplasty. BMC Musculoskelet Disord 2017; 18 (01) 8
  • 20 Rahman WA, Garbuz DS, Masri BA. Total hip arthroplasty in steroid-induced osteonecrosis: early functional and radiological outcomes. Can J Surg 2013; 56 (01) 41-46
  • 21 Alvarez AP, Demzik AL, Alvi HM, Hardt KD, Manning DW. Risk factors for postoperative urinary tract infections in patients undergoing total joint arthroplasty. Adv Orthop 2016; 2016: 7268985
  • 22 Keswani A, Tasi MC, Fields A, Lovy AJ, Moucha CS, Bozic KJ. Discharge destination after total joint arthroplasty: an analysis of postdischarge outcomes, placement risk factors, and recent trends. J Arthroplasty 2016; 31 (06) 1155-1162
  • 23 Peel TN, Dowsey MM, Daffy JR, Stanley PA, Choong PFM, Buising KL. Risk factors for prosthetic hip and knee infections according to arthroplasty site. J Hosp Infect 2011; 79 (02) 129-133
  • 24 Pugely AJ, Callaghan JJ, Martin CT, Cram P, Gao Y. Incidence of and risk factors for 30-day readmission following elective primary total joint arthroplasty: analysis from the ACS-NSQIP. J Arthroplasty 2013; 28 (09) 1499-1504
  • 25 Anon. User Guide for the 2014 ACS NSQIP Participant Use Data File (PUF). 2015 . Available at: https://www.facs.org/~/media/files/quality programs/nsqip/nsqip_puf_userguide_2014.ashx . Accessed December 2, 2016
  • 26 NSQIP. American College of Surgeons National Surgical Quality Improvement Program. n.d. Available at: https://www.facs.org/quality-programs/acs-nsqip? Accessed August 11, 2016
  • 27 Osman F, Saleh F, Jackson TD, Corrigan MA, Cil T. Increased postoperative complications in bilateral mastectomy patients compared to unilateral mastectomy: an analysis of the NSQIP database. Ann Surg Oncol 2013; 20 (10) 3212-3217
  • 28 Khuri SF. The NSQIP: a new frontier in surgery. Surgery 2005; 138 (05) 837-843
  • 29 Bozic KJ, Lau E, Kurtz S. , et al. Patient-related risk factors for periprosthetic joint infection and postoperative mortality following total hip arthroplasty in Medicare patients. J Bone Joint Surg Am 2012; 94 (09) 794-800
  • 30 Lee S, Hwang J-I, Kim Y, Yoon PW, Ahn J, Yoo JJ. Venous thromboembolism following hip and knee replacement arthroplasty in Korea: a nationwide study based on claims registry. J Korean Med Sci 2016; 31 (01) 80-88
  • 31 Cohen ME, Dimick JB, Bilimoria KY, Ko CY, Richards K, Hall BL. Risk adjustment in the American College of Surgeons National Surgical Quality Improvement Program: a comparison of logistic versus hierarchical modeling. J Am Coll Surg 2009; 209 (06) 687-693
  • 32 Cohen ME, Ko CY, Bilimoria KY. , et al. Optimizing ACS NSQIP modeling for evaluation of surgical quality and risk: patient risk adjustment, procedure mix adjustment, shrinkage adjustment, and surgical focus. J Am Coll Surg 2013; 217 (02) 336-46.e1
  • 33 Lawson EH, Louie R, Zingmond DS. , et al. A comparison of clinical registry versus administrative claims data for reporting of 30-day surgical complications. Ann Surg 2012; 256 (06) 973-981
  • 34 Higuera CA, Elsharkawy K, Klika AK, Brocone M, Barsoum WK. 2010 Mid-America Orthopaedic Association Physician in Training Award: predictors of early adverse outcomes after knee and hip arthroplasty in geriatric patients. Clin Orthop Relat Res 2011; 469 (05) 1391-1400
  • 35 Coursin DB, Wood KE. Corticosteroid supplementation for adrenal insufficiency. JAMA 2002; 287 (02) 236-240
  • 36 Boylan MR, Perfetti DC, Elmallah RK, Krebs VE, Paulino CB, Mont MA. Does chronic corticosteroid use increase risks of readmission, thromboembolism, and revision after THA?. Clin Orthop Relat Res 2016; 474 (03) 744-751
  • 37 Mednick RE, Alvi HM, Krishnan V, Lovecchio F, Manning DW. Factors affecting readmission rates following primary total hip arthroplasty. J Bone Joint Surg Am 2014; 96 (14) 1201-1209